会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 17. 发明申请
    • Treatments for neurogenetic disorders, impulse control disorder, and wound healing
    • 治疗神经源性疾病,冲动控制障碍和伤口愈合
    • US20020082222A1
    • 2002-06-27
    • US09997447
    • 2001-11-30
    • Nathan Andrew ShapiraMary Catherine LessigDaniel John Driscoll
    • A61K031/7024A61K031/351A61K031/255
    • A61K31/00A61K31/18A61K31/255A61K31/35A61K31/351A61K31/357A61K31/7024
    • The subject invention provides methods and compositions for the treatment of neurogenetic disorders, particularly DSM-IV impulse control disorders such as intermittent explosive disorder, kleptomania, pyromania, pathologic gambling, trichotillomania, and other impulse control disorders such as compulsive buying and problematic Internet use. In a preferred embodiment, the subject invention provides methods for treating or controlling symptoms associated with ADHD or PWS comprising the administration of therapeutically effective amounts of compositions containing compounds of the formulas I-V. In another embodiment, the subject invention provides for methods of promoting wound healing comprising the administration of a therapeutically effective amount of a composition comprising the compounds of formulas I-V. Compositions may administered to a wound site via a salve, ointment, or as a component of a bandage or bioadhesive applied to the site of injury. The invention also provides therapeutically effective compositions comprising one or more of the compounds of formulas I-V.
    • 本发明提供了用于治疗神经源性疾病,特别是DSM-IV脉冲控制障碍(例如间歇性爆发性疾病,克雷帕托尼亚,pyromania,病理性赌博,拔毛病等)和诸如强迫性购买和有问题的因特网使用的其它冲动控制障碍的方法和组合物。 在一个优选的实施方案中,本发明提供了治疗或控制与ADHD或PWS相关的症状的方法,包括施用治疗有效量的含有式I-V化合物的组合物。 在另一个实施方案中,本发明提供促进伤口愈合的方法,包括施用治疗有效量的包含式I-V化合物的组合物。 组合物可以通过药膏,软膏或作为施用于损伤部位的绷带或生物粘合剂的组分施用于伤口部位。 本发明还提供包含一种或多种式I-V化合物的治疗有效组合物。
    • 20. 发明申请
    • Composition and methods for treating subjects with hyperglycemia
    • 用于治疗高血糖患者的组合物和方法
    • US20040258773A1
    • 2004-12-23
    • US10487904
    • 2004-07-30
    • Xiaozhuo ChenFang LiuYungsheng LiJing Li
    • A61K035/78A61K031/7024
    • A61K31/7024A61K36/185
    • A partially purified plant extract for treating subjects who are hyperglycemic is provided. The partially-purified plant extract comprises a plurality of water soluble compounds having a molecular weight greater than 800 and less than 1500 grams/mole. One of the compounds in the partially-purified plant extract is the hydrolysable gallotannin known as penta-O-galloyl-D-glucose. The partially-purified plant extract is substantially free of triterpenoids, including corosolic acid and high molecular weight ellagitannins, i.e., ellagitannins having a molecular weight of greater than 1500 grams/mole. In a highly preferred embodiment, the partially purified plant extract is derived from the tropical plant Lagerstroemia Speciosa. L, which is also known as banaba. The present invention also relates to a method of using the present partially-purified extract to treat subjects who are hyperglycemic.
    • 提供了用于治疗高血糖患者的部分纯化的植物提取物。 部分纯化的植物提取物包含分子量大于800且小于1500克/摩尔的多种水溶性化合物。 部分纯化的植物提取物中的一种化合物是称为五-O-酰基-D-葡萄糖的可水解的gal单宁。 部分纯化的植物提取物基本上不含三萜类化合物,包括科罗索酸和高分子量鞣花素,即分子量大于1500克/摩尔的鞣花素。 在非常优选的实施方案中,部分纯化的植物提取物衍生自热带植物紫薇。 L,也被称为banaba。 本发明还涉及使用本发明部分纯化的提取物来治疗高血糖患者的方法。